Chemical denaturation and modification of ovalbumin alters its dependence on ubiquitin conjugation for class I antigen presentation.
Class I presentation of microinjected native OVA by a temperature-sensitive ubiquitin conjugation mutant, ts85, but not wild-type murine cells, was markedly inhibited following incubation at a nonpermissive temperature. In contrast, the nonpermissive temperature did not affect class I presentation of a minimal OVA peptide expressed in the cytosol. Therefore, these results provide a second example in which a temperature sensitive mutation in the ubiquitin conjugation pathway inhibits MHC class I presentation of native OVA. Surprisingly, incubation at the nonpermissive temperature did not inhibit class I presentation of chemically denatured and alkylated OVA microinjected into the cytosol of mutant cells. Similarly, the presentation of endogenously synthesized OVA (which is expressed from a recombinant vaccinia virus and, presumably, is misfolded in the cytosol) was also not inhibited in both mutant cell lines. Methylation of the lysine groups in denatured OVA, which blocks ubiquitin conjugation, reduced but did not eliminate the presentation of denatured OVA, providing evidence for both ubiquitin-dependent and ubiquitin-independent pathways for class I presentation. In contrast, a proteasome inhibitor blocked class I presentation of all forms of OVA, while a control peptide aldehyde was not inhibitory. These results indicate that modification of the structure of a protein can influence its requirements for ubiquitin conjugation for efficient class I presentation, with the key alteration possibly being the loss of proper conformation. However, regardless of the form of the Ag, the proteasome appears to be required for generating peptides from both endogenously synthesized and microinjected OVA for class I presentation.
Michalek
M T
MT
Alpha-Beta Technology, Worcester, MA 01605, USA.
Grant
E P
EP
Rock
K L
KL
D000595:Amino Acid Sequence; D000818:Animals; D017951:Antigen Presentation; D002460:Cell Line; D006224:Cricetinae; D003412:Cricetulus; D015395:Histocompatibility Antigens Class I / Q000737:chemistry* / Q000378:metabolism*; D008745:Methylation; D051379:Mice; D008845:Microinjections; D008969:Molecular Sequence Data; D010047:Ovalbumin / Q000096:biosynthesis / Q000378:metabolism* / Q000494:pharmacology; D011489:Protein Denaturation; D013696:Temperature; D014452:Ubiquitins / Q000378:metabolism*
D015395:Histocompatibility Antigens Class I; D014452:Ubiquitins; D010047:Ovalbumin